Cite
HARVARD Citation
Kalsi, G. et al. (n.d.). The efficacy and safety of genetically engineered allogeneic human chondrocytes expressing TGF-β1 in patients with grade 3 chronic degenerative joint disease of the knee. Osteoarthritis and cartilage. pp. S300-. [Online].